Skip to content
Forest Global Training Partners
Home Services AI Governance AI Navigators Contact Us
AI Navigators AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Risks
  3. AIDrug Development: FDA Releases Draft Guidance…

AI Risks January 20, 2025 · Mondaq

AIDrug Development: FDA Releases Draft Guidance - Healthcare - United States

In particular, the guidance outlines ariskframework based on a "context of use" of Artificial Intelligence(AI) technology and details the …

Read the original at Mondaq ↗

Topics
HealthcareGovernance & Risk Management
Mentions
FDAUnited States
Tags
AI Use Case
Tracked via
Google Alert “AI Risks”

Related articles

  • AIDrug Development: FDA Releases Draft Guidance | Foley & Lardner LLP AI Risks · Jan 15, 2025
  • FDA Releases FinalAIDevice PCCP Guidance - The National Law Review AI Risks · Jan 06, 2025
  • FDA unveils long-awaited guidance on AI use to support drug and biologic development AI Risks · Jan 23, 2025
  • FDA Issues Draft Guidance on Managing Cybersecurity Risks AffectingAI-Enabled Devices AI Risks · Feb 12, 2025
  • FDA Issues Draft Guidance onAI-Enabled Medical Devices AI Risks · Feb 17, 2025
  • FDA offers new draft guidance to developers ofAI-enabled medical devices AI Risks · Jan 06, 2025

Shares players with

  • 3 Under-the-Radar IPO Stocks to Buy Before They Double | Investor Place
  • Personalis 13D Filing Shows Tempus AI Reported A 15.1% Stake In The Co As Of July 3, 2024
  • United States: What's Special About AI Risks And Remedies In Health Care? - Mondaq
  • FDA unveils long-awaited guidance on AI use to support drug and biologic development
  • Without FDA Regulation,AITech in Healthcare Poses Dire Risksto Patients - Public Citizen
  • FDA Flags Cyber, AI Risks in Autonomous Medical Robots - BankInfoSecurity

AI Navigators is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact